Cencora (COR) Shares Outstanding (Weighted Average) (2009 - 2026)
Cencora (COR) reported Shares Outstanding (Weighted Average) of $194.4 million for Q1 2026, little changed on a YoY basis from $193.8 million in Q1 2025, and little changed quarter-over-quarter from $194.2 million in Q4 2025.
Cencora (COR) Shares Outstanding (Weighted Average) (2009 - 2026) Analysis & Trends
Cencora has reported Shares Outstanding (Weighted Average) for 18 years, with the latest figure at $194.4 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) changed 0.3% year-over-year to $194.4 million; the trailing twelve-month figure through Mar 2026 stood at $194.4 million (changed 0.3% YoY), and the FY2025 full-year result was $193.8 million, down 2.36% from the prior year.
- Shares Outstanding (Weighted Average) for Q1 2026 stood at $194.4 million, roughly flat from $194.2 million in the prior quarter.
- The five-year high for Shares Outstanding (Weighted Average) was $209.2 million in Q1 2022, with the low at $193.8 million in Q4 2024.
- Historically, Shares Outstanding (Weighted Average) has averaged $199.9 million across 5 years, with a median of $199.4 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) rose 2.11% — and 2023, when it decreased 3.31%.
- Cencora's Shares Outstanding (Weighted Average) stood at $204.0 million in 2022, then retreated by 1.94% to $200.1 million in 2023, then declined by 3.16% to $193.8 million in 2024, then increased by 0.24% to $194.2 million in 2025, then climbed by 0.08% to $194.4 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $194.4 million (Q1 2026), $194.2 million (Q4 2025), and $193.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 1,767,296.88 Bn |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 123.60 Mn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 194.38 Mn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 235.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 114.94 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 76.43 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 37.48 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 24.54 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 47.09 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | 14.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 194.38 Mn |
| Dec 31, 2025 | 194.22 Mn |
| Sep 30, 2025 | 193.82 Mn |
| Jun 30, 2025 | 193.79 Mn |
| Mar 31, 2025 | 193.80 Mn |
| Dec 31, 2024 | 193.76 Mn |
| Sep 30, 2024 | 198.50 Mn |
| Jun 30, 2024 | 198.26 Mn |
| Mar 31, 2024 | 199.41 Mn |
| Dec 31, 2023 | 200.08 Mn |
| Sep 30, 2023 | 202.51 Mn |
| Jun 30, 2023 | 202.91 Mn |
| Mar 31, 2023 | 202.32 Mn |
| Dec 31, 2022 | 204.03 Mn |
| Sep 30, 2022 | 208.47 Mn |
| Jun 30, 2022 | 208.89 Mn |
| Mar 31, 2022 | 209.24 Mn |
| Dec 31, 2021 | 208.56 Mn |
| Sep 30, 2021 | 205.92 Mn |
| Jun 30, 2021 | 205.26 Mn |